A Study of HPV Specific Immunotherapy in Subjects With HPV6 Associated Aerodigestive Precancerous Lesions and Malignancies
Phase of Trial: Phase I
Latest Information Update: 23 Oct 2018
Price : $35 *
At a glance
- Drugs INO 3107 (Primary) ; INO 9012 (Primary)
- Indications Head and neck cancer; Human papillomavirus infections; Lung cancer; Squamous cell cancer
- Focus Adverse reactions
- Sponsors Inovio Pharmaceuticals
- 15 Oct 2018 Status changed from active, no longer recruiting to completed.
- 24 Jul 2018 Planned End Date changed from 1 Dec 2018 to 1 Sep 2018.
- 24 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Sep 2018.